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Recently, the notion that loiasis is
mostly a benign disease has been
challenged. A cohort study in Camer-
oon showed a significant association
between heavy Loa loamicrofilaraemia
and increased human mortality risk.
Across Central Africa >10 million peo-
ple are estimated to have loiasis.
Mathematical models of neglected
tropical diseases (NTDs) can inform
the implementation and evaluation of
interventions aimed at controlling and
eliminating these diseases. Loa loa is
not among the 20 NTDs on the World
Health Organization’s list, and mathe-
matical models for its transmission and
control have never been formulated.
Little attention has been paid to asses-
sing fundamental parasitological,
entomological, and epidemiological
processes that must be adequately
quantified in mathematical models if
these are to be developed as useful
tools for optimal and cost-effective
intervention design.
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Montpellier, FranceEndemic to Central Africa, loiasis – or African eye worm (caused by the filarial
nematode Loa loa) – affects more than 10 million people. Despite causing
ocular and systemic symptoms, it has typically been considered a benign
condition, only of public health relevance because it impedes mass drug
administration-based interventions against onchocerciasis and lymphatic fila-
riasis in co-endemic areas. Recent research has challenged this conception,
demonstrating excess mortality associated with high levels of infection, imply-
ing that loiasis warrants attention as an intrinsic public health problem. This
review summarises available information on the key parasitological, entomo-
logical, and epidemiological characteristics of the infection and argues for the
mobilisation of resources to control the disease, and the development of a
mathematical transmission model to guide deployment of interventions.
[290_TD$DIFF]Loa loa: More Than Meets the Eye
The filarial nematode [291_TD$DIFF]Loa loa (Cobbold, 1864), which is transmitted from human to human by
tabanid flies (Diptera: Tabanidae) of the genus Chrysops, causes loiasis, a pathological
condition often labelled as ‘African eye worm’. Loiasis is endemic in heavily forested areas
of Central Africa, including Cameroon, Democratic Republic of the Congo (DRC), Gabon, and
Nigeria, where a combination of long adult worm lifespans (>20 years in some instances [1])
and continuous exposure to infective bites mean [292_TD$DIFF]that individuals can harbour the worm for
nearly their entire life. L. loa can cause both ocular and systemic symptoms; these include eye
worm, caused by the migration of the worm under the bulbar conjunctiva (see Glossary), as
well as subcutaneous oedemas known as Calabar swellings, which are thought to be caused
by immunogenic reactions to the release of eithermicrofilariae or antigenic material by adult
worms [2]. Both manifestations are considered mild and without significant morbidity or impact
on quality of life. More rarely, disease sequelae can prove more severe, including a variety of
cardiac, renal, and neurological complications [3].
Despite this range of clinical manifestations, and that over 14 million people currently reside in
high-risk areas [4], loiasis has typically been considered a benign condition and, in contrast to
other filarial infections such as onchocerciasis and lymphatic filariasis (LF), has not been
included in the World Health Organization’s list of neglected tropical diseases (NTDs)[293_TD$DIFF]
Appendix A. Recent research on the epidemiology of L. loa has been primarily concerned with
the impediment it poses to the treatment of onchocerciasis and LF in individuals with high levels
of L. loamicrofilariae circulating in the bloodstream. These individuals have a greatly increased
risk of developing severe adverse events (SAEs) if treated with ivermectin. Hence, in areas
where loiasis is co[289_TD$DIFF]-endemic with onchocerciasis and/or LF, the ability to safely carry outmass
drug administration (MDA)with ivermectin (the cornerstone of onchocerciasis and LF control
efforts in Africa) is impeded [5,6].Trends in Parasitology, Month Year, Vol. xx, No. yy https://doi.org/10.1016/j.pt.2017.12.003 1
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(M.-G. Basáñez).Whilst the parasite’s capacity to cause clinical disease has long been recognised, it is only
recently that epidemiological studies have started to uncover the impact of loiasis on human
morbidity and mortality. Most notably, a cohort study in an area of Cameroon (that has never
been included in ivermectin MDA programmes) revealed a significant association between
infection profiles characterized by high levels of L. loamicrofilaraemia (microfilariae in the blood)
and an increased relative risk of mortality [7]. Indeed, the population attributable fraction of
mortality associatedwith loiasis was 14.5%, greater than the estimated 5% (acrossWest Africa)
caused by onchocerciasis [8]. This indicates that long-held conceptions of loiasis as a benign
disease are misplaced, and that loiasis warrants attention as a public health issue in its own
right, and not merely as a barrier to the treatment of other filarial diseases.
Mathematical transmission models of NTDs are increasingly being used to guide and quantify
the impact of interventions aimed at controlling and eliminating NTDs and improving the health
of many of the world’smost impoverished populations. Yet for L. loa, no suchmodels exist, and
little attention has been paid to the fundamental population biological processes that underpin
model development. Previous reviews have focused on entomological, clinical, and immuno-
logical aspects of loiasis [9,10], but a review summarising the pertinent epidemiological,
population biology, and transmission dynamics features of the parasite remains outstanding.
In the context of loiasis’ newly uncovered public health importance [7], this review addresses
this absence, making the case for increased interest and effort in researching the disease, and
advocating [294_TD$DIFF]for mobilisation of resources for its control using strategies guided by mathematical
modelling.
Parasite Biology and Life Cycle
Adult L. loa reside [285_TD$DIFF]in the layers of loose connective tissue beneath the skin, as well as between
the fascial layers on top of somatic muscles [11], where they produce large numbers of
embryonic progeny called microfilariae. Unlike other filariae, L. loa lacks Wolbachia endo-
symbionts [12,13], although it does not appear to have developed any novel specialised
metabolic capabilities in compensation [14].
Microfilariae circulate in the peripheral blood during the daytime and, following ingestion during
a bloodmeal, develop within the vector to infective (L3) stages during a process taking between
10 and 12 days (Figure 1). This duration of the extrinsic incubation period (EIP) is consis-
tently reported in numerous studies conducted across Central Africa and across the two main
species of Chrysops (Chrysops silacea and Chrysops dimidiata) responsible for human trans-
mission [15,16], although the EIP is likely to vary with ambient temperature [17]. Indeed, there
are reports of developmental times taking as long as 3–4 weeks in the cooler mountain valley
regions of Cameroon (situated 4000 feet, i.e., 1200 m above sea level) [18]. Whilst most
research suggests that nearly all microfilariae ingested successfully develop into L3 larvae, and
that there is little parasite mortality within the vector [3,9,19], only one experiment has actually
been carried out to assess this, which concluded that ‘the number of infective forms found in
flies . . . is similar to the number of the microfilariae taken in’ [20]. Our reassessment of these
results, however, suggests that the actual proportion of ingestedmicrofilariae progressing to L3
is lower, in the region of 40–50% (C. Whittaker, MSc thesis, Imperial College London, 2017).
It is not known whether this proportion varies in a density-dependent manner with microfilarial
intake, as has been observed for other filarial parasites such as Onchocerca volvulus [21] and
Wuchereria bancrofti [22].
Upon inoculation into humans, L3 larvae undergo a third moult to become fourth-stage larvae
(L4), and then a fourth and final moult to become young adult worms. After sexual maturation2 Trends in Parasitology, Month Year, Vol. xx, No. yy
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Glossary
Amicrofilaraemic: a term used to
denote individuals with no detectable
levels of microfilariae in their blood.
Bulbar conjunctiva: the portion of
the conjunctiva (a clear thin
membrane that covers the front
surface of the eye) covering the
‘whites’ of the eye.
Diethylcarbamazine (N,N-diethyl-
4-methyl-1-piperazine
carboxamide, DEC): a medication
used to treat lymphatic filariasis in
endemic areas other than those in
Africa as it is contraindicated in
onchocerciasis.
Extrinsic incubation period (EIP):
in vector-borne diseases, the interval
between the acquisition of the stages
infectious to the vector and the
transmission of the stages infective
to other susceptible vertebrate hosts.
As arthropod vectors are
poikilotherms, the EIP depends on
temperature.
Lymphatic filariasis (LF):
commonly known as elephantiasis,
LF is a neglected tropical disease
caused by infection with lymphatic
filariae (Wuchereria bancrofti, Brugia
malayi, Brugia timori) transmitted to
humans through the bites of
mosquitoes.
Mass drug administration (MDA):
the treatment, with a
chemotherapeutic agent, of a
population or population group
considered to be at risk of infection
in a geographical area without first
diagnosing the infection, and
regardless of the presence of
symptoms.
Maximum likelihood: a
mathematical method for estimating
the parameters of a statistical model
when such a model is fitted to data.
The likelihood is the probability of
observing a particular set of sample
data given a particular statistical
model and parameters. Maximum
likelihood estimation involves finding
the values of the parameter(s) that
‘maximise’ the likelihood of observing
the data.
Microfilariae: an early stage in the
life cycle of Loa loa and other filarial
nematodes. Produced by
reproductively active adult females,
this embryonic stage of the parasite
circulates in the peripheral blood of
humans and is taken up during
blood feeding by the Chrysopsand development into fully reproductive adult worms, females produce microfilariae that
periodically accumulate in the peripheral blood and are ingested by vectors during a bloodmeal.
Estimates of the timings of these developmental processes are varied, with observed differ-
ences likely due to experiments having been conducted in different model organisms. In rodent
animal models, the L3 to L4 transition occurs approximately 9 days after inoculation, with the
transition from L4 to young adult taking place around day 20 [23]. In monkeys, by contrast,
these transitions happen 16–20 and about 30 days after inoculation, respectively [24]. Despite
this, microfilariae are not detected in the peripheral blood until 5 to 6 months later [11,25],
implying some further delay in either their production (possibly caused by the time taken for
adult sexual maturation and mating) or their release into the peripheral bloodstream from the
lungs.
Fecundity and Microfilarial Production
Upon fertilisation, female worms produce microfilariae, each surrounded by a sheath formed
from part of the initial egg shell. Studies of microfilarial production have been limited, but results
of single-pair infections indicate that each female adult worm can produce between 12 000 and
39 000 microfilariae per day in the absence of reproductive constraints [26]. These estimates
agree with our reanalysis (Figure 2) of similar data involving experimentally infected primates
[25], in which we have estimated fecundity, microfilarial lifespan, and rate of progression from
inoculated L3 larvae into reproductively active female worms. Differences in these estimates
were observed across data from different animal models, including patas monkeys (Eryth-
rocebus patas, not a natural host; Figure 2A) and baboons (Papio anubis, a natural host;
Figure 2B). Estimates of adult worm lifespan are rare, but the average (life expectancy) is
thought to be at least 9 years [25], with reports of some worms surviving for as long as 15–21
years [1,27,28].
A non [295_TD$DIFF]-linear relationship appears to exist between the number of adult worms an individual
harbours and the observed intensity of infection with microfilariae, with single-pair infections
capable of producing concentrations of microfilariae in the blood similar to those of infections
composed of several pairs of worms [25]. Such variability in infection intensities has also been
observed in more recent work, where a number of baboons, all infected with 600 L3 larvae,
displayed as much as a 50-fold difference in their resulting microfilarial loads [29] (such a
phenomenon is similar to that observed for Ascaris suum in experimentally and naturally
infected pigs [30]). There is, however, some positive correlation between the number of worms
harboured and the resulting concentration of microfilariae in the blood, with other research also
involving experimental infection of primates demonstrating that, whilst monkeys inoculated with
200 L3 larvae had, on average, higher concentrations of microfilariae than those inoculated with
75 L3 larvae, there was significant overlap between infection intensities observed across the
two groups [25]. The results are, therefore, suggestive of some non[295_TD$DIFF]-linear (and possibly
density-dependent) relationship between worm burden and microfilaraemia, a phenomenon
reminiscent of that directly observed for Ascaris lumbricoides [31] and suggested for O.
volvulus [32] (although, in the latter case, other studies have failed to substantiate these
findings [33]). Although it is apparent that worm burden and microfilarial intensity are not
linearly related, it remains to be established whether this is a product of density-dependent
processes acting on female worm fecundity, or on other aspects of parasite or host biology.
Of the microfilariae produced by adult worms, only a small proportion are present at any given
time in the peripheral blood and become available for ingestion during a bloodmeal byChrysops
species vectors. Some estimates have used a value of 10%, based on studies conducted using
the dog heartworm Dirofilaria immitis [26,34], whereas others have estimated it directly asTrends in Parasitology, Month Year, Vol. xx, No. yy 3
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horsefly species that act as vectors
of the parasite.
Neglected tropical diseases
(NTDs): an umbrella term
encompassing a diverse group of
(mostly) communicable diseases of
poverty (excluding malaria, HIV, and
TB), which was coined against the
backdrop of these ‘big three’ to raise
the profile of, and unite efforts
against tropical/sub-tropical
infections/conditions. NTDs are
particularly prevalent in low- and
middle-income populations in
developing regions of Africa, Asia,
and the Americas. They are caused
by a variety of pathogens, including
viruses, bacteria, protozoa and
helminths.
Overdispersion: in statistics and
parasitology, the presence of greater
variability (statistical dispersion
around the mean) than would be
expected based on a given (generally
Poisson) distribution. As in the
Poisson (random) distribution, the
variance is equal to the mean (the
variance to mean ratio, VMR, is
equal to 1), an overdispersed
distribution has a VMR >>1. The
number of parasites per host is more
often than not overdispersed.
Severe adverse event (SAE): any
untoward medical occurrence during
a drug clinical trial or following an
approved treatment that: results in
death; is life-threatening; requires
inpatient hospitalization or causes
prolongation of existing
hospitalization; results in persistent or
significant disability/incapacity; leads
to a congenital anomaly/birth defect,
or requires intervention to prevent
permanent impairment or damage.between 5% and 20% based on experimental infections in primate species and comparison of
microfilarial concentrations in pulmonary and peripheral blood [11].
Whilst previous historical estimates of microfilarial lifespan placed it in the region of
6–12 months [11], this was primarily based on empirical observations of the time taken for
microfilarial counts to stabilise and plateau in infected primates. Our analysis of more recently
published data [24] suggests that the average lifespan is shorter, between 3 and 5 months
(Figure 2C).
Vector Biology and Life Cycle
Chrysops Species Vectors of L. loa
In humans, L. loa is transmitted primarily by two species of the tabanid family, C. silacea and C.
dimidiata. They are found across the tropical rainforests of Central and Western Africa,
alongside other Chrysops species, including Chyrsops langi, Chrysops centurionis, Chrysops
zahrai andChrysops longicornis. These species are not considered to be primary vectors of the
human strain of L. loa, and instead are thought to contribute to the maintenance of the simian
form of the infection (discussed below) through their crepuscular/nocturnal biting habits
(simian L. loa exhibits nocturnal periodicity of microfilarial circulation in the peripheral blood),
and preference for primate bloodmeals [10]. Whilst C. silacea has been more abundant than
C. dimidiata at many of the sites studied [35], others have observed C. dimidiata to be more
abundant [36], highlighting the importance of local ecological factors in underpinning species’
abundance. Both species exhibit a strong annual variation in abundance, peaking during the
rainy season for C. silacea, and somewhat earlier for C. dimidiata [37].
Biting Patterns and Transmission
C. silacea and C. dimidiata display similar feeding patterns and host preferences. Both species
show strong diurnal biting preferences, with biting activity being greatest during the morning
(approximately 9–11 a.m.) and late afternoon (approximately 2–4 p.m.), coinciding with the
appearance of L. loa microfilariae in the blood of infected humans, with microfilaraemia in
infected individuals typically peaking somewhere between 10 a.m. and 4 p.m. [38,39]. It is
estimated that both species bite once every 5 days [40], coherent with the estimates of 5–
6 days for the duration of the gonotrophic cycle [41,42]. Biting frequency appears somewhat
variable, however, and has been shown to increase with temperature but decline with relative
humidity [38]. Unlike other flies, both species are heavily attracted by the smoke of wood fires,
which significantly increases biting densities [43], although the species appear differentially
sensitive to it as an attractant (with C. silacea biting densities increasing 11-fold and Chrysops
dimidiata 4.5-fold [44]). Humans constitute the vector’smain blood source; approximately 90%
of bloodmeals are taken on them, with a mixture of wild animals (not including primates, limiting
the capacity for cross-transmission) making up the remainder [45]. Whilst historically it has been
suggested that the biting habits of parous and nulliparous flies differ, with parity determining
whether flies bite in the morning or late afternoon [46], more recent work has not confirmed
such a difference, and it appears that the biting habits of nulliparous and parous flies are broadly
similar [39].
Estimates of average bloodmeal size (a key determinant alongwith host microfilarial levels of the
number of microfilariae ingested) vary across the literature, depending on a number of factors
including whether flies were allowed to feed to repletion and whether the study was conducted
in a laboratory or in a natural setting. The typical bloodmeal size in C. silacea, when allowed to
feed to repletion under laboratory conditions, is about 40 mg [47,48], varying between 25 and
55 mg. Under natural conditions, bloodmeal size in both C. silacea and C. dimidiata is smaller,4 Trends in Parasitology, Month Year, Vol. xx, No. yy
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Figure 1.
(Figure legend continued on the bottom of the next page.)
The Life Cycle and Development of Loa loa. Adult L. loa reside [285_TD$DIFF]in the subcutaneous tissue of the human host, where males and females mate and
produce microfilariae. Microfilariae (MF) accumulate in the pulmonary blood and periodically in the peripheral blood, where they can be transmitted to tabanid vectors
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TREPAR 1719 No. of Pages 16averaging 25 mg and 20 mg, respectively [19]. Estimates of the frequency with whichChrysops
species feed to repletion in the wild are lacking, although feeding to repletion is not necessary
for ovary development, with bloodmeals above 14 mg shown to be sufficient for normal
development of both the ovaries and any ingested L. loa microfilariae [42]. The actual bite
itself is not painful, with the often reported pain of the bite actually associated with the
withdrawal of biting parts upon completion of the bloodmeal [16]. Thus, many hosts usually
notice the bite only after the fly has finished feeding. It’s more common, perhaps, for individuals
to notice the landing of the fly and brush it away before feeding commences, a possible
consequence of their large size and striking patterned colour [49]. One report from Gabon, for
example, suggests that the proportion of landings that successfully translates into bloodmeals
is 14% [50].
It has been noted that the intake of microfilariae in flies fed on infected individuals is lower than
would be expected based on the size of the bloodmeal and the concentration of microfilariae in
the host’s blood [48]. This might be a product of the mechanism by which Chrysops feeds,
which involves feeding from a pool of blood produced by laceration [51], rather than from a
capillary, as is common for other species of blood-feeding insects (particularly mosquitoes).
It has been postulated that there might be a delay in the accumulation of microfilariae in this
pool, such that the fly ingests a smaller amount than would be expected.
Vector Mortality, Competence, and Carriage of L3 Larvae
Microfilariae are thought to develop into L3 larvae in the fat body of the fly [52] before dispersing
widely throughout the body of Chrysops, although strictly emerging from the fly’s head when it
takes a bloodmeal. It is suggested that these larvae are able to move freely between the body
and the head, such that L3 larvae from other parts of the body can be recruited to the head
during times of feeding [51].
The emergence of L3 larvae from the vector’s head is thought to incur a significant amount of
excess mortality, something perhaps not surprising given the large number of larvae that flies
typically carry; it is not uncommon for flies to harbour upwards of 100 L3 larvae [53]. The
emergence of larvae from the head causes great irritation to the fly, eliciting proboscis ‘milking’
actions associated with stress, and damage to the labio[296_TD$DIFF]-hypopharyngeal membrane and
musculature [54]. Indeed, whilst it has been shown experimentally that flies can remain infective
for up to 5 days following the first L3 larval emergence, with infective larvae emerging each time
a bloodmeal is taken over that period, the vast majority of flies die within 24 h of taking a
bloodmeal in which L3 larvae emerge [16]. Hence, a single fly is very unlikely to transmit infection
more than once during its lifetime.
Vector lifespan is of a duration comparable to that of the EIP of L. loa, and is significantly
reduced by carriage of the parasite (independently of the high mortality rate associated with the
emergence of infective L3 larvae; Figure 3). Earlier reviews have suggested that only 10% of fliesbelonging to theChrysops genus, primarilyChrysops silacea andChrysops dimidiata, during ingestion of a bloodmeal. Once ingested by the fly, and in a process taking
10–12 days, microfilariae develop into the third stage (L3) larvae, the stage capable of infecting people. This process is characterised by the transition between a number
of discrete larval forms, with the microfilaria to L1 transition taking approximately 2 days, the L1 to L2 transition 4 days, and the L2 to L3, 4 days [100]. The L3 larvae
reside primarily in either the abdomen or head, and upon initiation of a bloodmeal, are recruited from both sites, where they emerge and quickly escape into the
cutaneous laceration inflicted by the fly in order to feed [52]. Once inside their human host, L3 larvae mature and moult, firstly into L4 larvae and then into juvenile worms
(sometimes called L5 larvae) in a developmental processes taking 16–20 and 30 days, respectively [24]. The appearance of microfilariae in the bloodstream does not
occur until much later, often as long as 150–170 days after infection [25], implying the existence of a further delay following development into a juvenile worm before
adults become fully mature, capable of reproduction and production of microfilariae. Little is known about the lifespan of adult worms, although reports indicate that they
can live for as long as 21 years [1].
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Figure 2. Estimating Parasite Population Biology Parameters. Counts of blood microfilariae (MF) in a patas monkey (Erythrocebus patas) infected with 75 L3
larvae (panel A, open circles), and a baboon (Papio anubis) infected with one female and two male juvenile worms (panel B, open circles) were extracted from [25].
Mathematical models were fitted to these data (panels A and B, red line) using maximum likelihood. The specific pre[286_TD$DIFF]-patent interval (time between infection and
appearance of microfilariae in the peripheral blood) for each individual animal was not reported and so the average pre[286_TD$DIFF]-patent period for each species (reported) was
used in each case for purposes of calculating the pre [286_TD$DIFF]-patent period. Both primates were splenectomised, and pre [287_TD$DIFF]-splenectomy data were excluded due to the known
involvement of the spleen in clearing infection in primates [11]. Data from experimental primate infections [26] were used to estimate key population biology parameters,
namely average adult worm fecundity (e), larval maturation (g) and microfilarial mortality (mM) rates (panel D). The models fitted to the data are elaborations of the
immigration-death framework [65] (panel C) incorporating a number of intermediate latent parasite stage compartments (n). This changes the distribution of maturation
times or pre[286_TD$DIFF]-patent periods without changing the mean of the distribution. For one compartment (the default for numerous population dynamics models), times are
exponentially distributed. For increasing n, times are gamma distributed with shape factor given by integer n (strictly an Erlang distribution), leading to progressive
narrowing and increased symmetry of the distribution. The best-fitting models included 22 and 75 compartments for the data from the patas monkey (panel A) and
baboon (panel B), respectively, congruent with the inoculum used in each case (75 compartments yield a narrow distribution of maturation times approaching a point
estimate, coherent with the fact the inoculum consisted of a single female worm). By contrast, 22 compartments result in a range of times, consistent with the patas
monkey having been infected with a large number (75) of L3 larvae. To accommodate decreases in microfilarial concentration (panel B) (despite necropsy of the baboon
yielding a living female worm), it was assumed that the inoculated males had ceased inseminating the female, or that senescence of the female had led to declining
fecundity, which was modelled as exponentially declining over time; model fitting suggested fecundity to have begun declining at week 106, reaching 5% of its initial
value by week 146. Little is known about the reproductive lifespan of Loa loa, but in Onchocerca volvulus, it is about 9–11 years, with simulated declines in fecundity
starting from the patent age of 5 years and reaching 0 at age 20 [101], significantly longer than the times reported here, where decline starts at 2 years and is complete by
4 years. The differing fecundity, maturation, and microfilarial mortality rate estimates reported in panel (D) may reflect physiological differences between the two primate
species because baboons are natural hosts for L. loa, whereas patas monkeys are not.survive theminimum 10 days required for microfilariae to develop into L3 larvae [3], and only 5%
survive past the estimated 12-day upper bound of the EIP [41]. Whilst it is usually assumed that
carriage of developing larvae incurs no excess mortality in the fly, our reanalysis of historical
data shows a significant difference in survivorship between flies infected with high and low L. loaTrends in Parasitology, Month Year, Vol. xx, No. yy 7
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TREPAR 1719 No. of Pages 16loads (Figure 3A,B). Fitting a piecewise exponential hazard function to the data highlights that
much of the excess mortality arises from the ingestion of high numbers of microfilariae,
occurring within the first 2–3 days following a bloodmeal (Figure 3C). This is similar to obser-
vations on excess mortality in blackflies ingesting O. volvulusmicrofilariae [54]. This conclusion
is further supported by less formal evidence from other studies suggesting that infection with
the parasite, and the intensity of the infection, both influence vector mortality [41,55].
Epidemiology of Loiasis
Geographical Distribution, Disease, and Host Species
L. loa is endemic across much of Central Africa, a region that is home to well over 30 million
people [4], with areas within the DRC and Cameroon together accounting for almost 40% of the
population at risk. An estimated 14 million individuals reside in high-risk areas, where the
prevalence of eye worm passage (history of eye worm) is greater than 40% [4] (implying current
or past infection with adult worms).
Clinical indicators of disease appear anywhere from 2 months [56] to 21 years [1] after initial
infection. Most commonly observed symptoms include ‘eye worm’ and Calabar swellings [2],
as well as a number of rarer, more severe pathologies, including renal, cardiac, and neurological
involvement [3,57]. Besides this, treatment with ivermectin or diethylcarbamazine (DEC) of
subjects presenting very high microfilarial densities can induce, within 1–3 days, a specific and
potentially fatal encephalopathy.
In addition to infecting humans, several primate species (including the yellow baboon, Papio
cynocephalus [58] and the mangabey, Cercocebus albigena [59], amongst others) have been
found to be naturally infected with a strain of Loa. Although these parasites appear to belong to
the same species that infects humans (as evidenced by their capacity to produce fecund
hybrids with the human-infecting parasites [60]) the overall contribution of simian hosts to
human loiasis is considered minimal due to the differing biting habits of their respective vectors
(C. silacea andC. dimidiata for human Loa;C. langi andC. centurionis for the simian strain) and
the differing periodicities of microfilarial circulation in the peripheral blood (adapted to the
biting habits of their vectors – diurnal for human Loa, nocturnal for the simian form) [10,61].(See figure legend on the bottom of the next page.)
Figure 3. Estimating the Impact of Infection on Vector Mortality. Data from experimental feeding experiments were
analysed to assess whether the ingested concentration of microfilariae from human blood affects tabanid Chrysops
species mortality and lifespan. Data were taken from [16] and comprise two groups of flies fed on people with either ‘high’
or ‘low’ concentrations of microfilariae in their blood (exact concentrations not given; panel A). Comparison of Kaplan–
Meier survival curves for the two groups of flies (panel B) revealed a significant difference in survival (P = 0.0049, Mantel–
Haenszel test). The main differentiating feature between the two curves occurs in the first 2 days, where flies feeding on
humans with a high microfilarial concentration had greater mortality than flies feeding on humans with low concentrations.
This is in keeping with observations on Simulium species of blackfly vectors of Onchocerca volvulus, in which ingestion of
high microfilarial loads by the fly is associated with substantial excess mortality [54]. Motivated by this, a piecewise
exponential model was fitted to the data (panel B), with different (constant) hazards over the initial 3 days but the same
thereafter. Proportional hazards were assumed for the two groups of flies, and models were fitted using maximum
likelihood techniques. The results confirmed a statistically significant 4.67-fold greater hazard for the first 3 days after
ingestion of microfilariae in the flies feeding on humans with high concentrations compared to flies feeding on humans with
low concentrations (panel C). By contrast, after the first 3 days, the difference in hazards between the two groups was
negligible and not statistically significant. This suggest that higher intensity infections significantly impact vector mortality in
a density-dependent manner. This conclusion is further supported by other research comparing flies fed on infected
mandrills and uninfected rats which, although not producing a statistically significant difference, shows an appreciable
difference between the mortality of infected and uninfected flies [41]. Other, older data also support this, with research by
Kershaw et al. [55] suggesting that tabanid horseflies infected with Loa loa microfilariae have a lower life expectancy than
their uninfected counterparts. It is, however, important to note that this same research also observed highly infected flies
living longer than flies with low-intensity infections, although interpretation of these results is complicated greatly by the
presence ofMansonella perstans co[288_TD$DIFF]-infection and a small sample size compared to the data from Connal and Connal [16].
Trends in Parasitology, Month Year, Vol. xx, No. yy 9
TREPAR 1719 No. of Pages 16These factors are thought to contribute to the spatial and temporal separation of transmission
between the two strains, although the possibility of some cross-transmission between host
species should not be completely ruled out.
Prevalence and Intensity of Infection in Human Populations
A number of studies have observed that the community prevalence of L. loa microfilaraemia
saturates between 50% and 60% (in the regions of highest endemicity) with increasing average
microfilarial load (infection intensity; mean number of microfilariae per ml of blood) [62,63].
Prevalence and intensity remain fairly constant over time [64], indicating endemic stability and
therefore the operation of density-dependent processes constraining the growth of the parasite
population [65]. In onchocerciasis, density-dependent processes operate on microfilarial
establishment within the (blackfly) vector [21], on (excess) vector mortality [54], and on adult
worm establishment (with increasing annual transmission potential) in humans [66]. Research
into the necessary processes that regulate L. loa populations is limited, but evidence from our
own analysis of historical data (Figure 3), as well as more contemporary results (see below),
supports the existence of excess vector mortality induced by ingestion of microfilariae. Whether
other density-dependent processes operate in the L. loa life cycle remains unknown.
The shape of the loiasis prevalence–intensity relationship is superficially similar to that observed
for other filarial infections such as onchocerciasis [67], as well as other helminth infections like
schistosomiasis [68], except that in the latter two, the prevalence of infection with transmission
stages (microfilariae or parasite eggs, respectively) can reach nearly 100% as infection intensity
increases. This relationship has been explained by suggesting that the degree of parasite
overdispersion among hosts (probably driven by heterogeneous exposure to infection)
decreases as mean infection intensity rises, allowing for infection prevalence to reach high
values (nearly 100%) when intensity is high. Interestingly, previous studies have suggested that
the degree of L. loa overdispersion across communities is severe and does not change with
mean infection intensity [69], an observation that could lead to the lower levels (50–60%) of
saturating microfilarial prevalence that have been reported.
There are other notable differences in the epidemiology of loiasis compared with other
helminthiases. The first is that the intensity of infection (microfilariae per ml of blood) has
the capacity to far exceed that observed for other blood-dwelling filarial parasites. Very high
microfilarial concentrations, reaching 50 000 per ml of blood, are not uncommon [70] and differ
notably from values reported for LF, in which microfilarial concentrations in the blood rarely
exceed 20 000 per [297_TD$DIFF]mlAppendix A [71]. The second is that a high proportion of parasitised
subjects (as determined by signs of apparent infection such as history of eyeworm), do not
present with microfilaraemia (although a similar phenomenon is also observed in LF [72]).
Indeed, despite high prevalence of apparent infection (history of eyeworm), which in hyperen-
demic regions can surpass 70% [4], with 95% of the population possessing antibodies reacting
with L. loa antigens by the age of 2 years [73], the proportion of people with microfilaraemia
(assessed by microscopy) is often far lower, typically representing 30–40% of the total
population, and only 50–60% in highly endemic areas (and even then only in adults older
than 50 years of age) [70]. It is often, therefore, concluded that a substantial fraction of the
population is amicrofilaraemic [74].
Part of this disparity among current measures of detecting infections might be explained by the
sensitivity of the diagnostics. The capacity of blood smears to accurately detect microfilariae in
individuals with very low infection intensities is limited; resampling of individuals over time,
studying larger volumes of blood than usually used in the thick smears used for microscopic10 Trends in Parasitology, Month Year, Vol. xx, No. yy
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significant proportion of apparently amicrofilaraemic individuals do in fact harbour microfilariae,
albeit at levels below those detectable by microscopy [75–78]. The proportion of people who
are actually microfilaraemic despite negative blood smears remains to be assessed, as does
the reason behind the highly variable levels of microfilaraemia that can be seen in members of
the same community (microfilarial concentrations ranging from 0 to more than 200 000 micro-
filariae per ml of blood, as quantified by microscopy [79,80]).
Heterogeneity in microfilarial concentrations could be caused by differences in exposure
among individuals, innate differences in genetic traits [81] that mediate susceptibility to infec-
tion, immunological factors [82] that influence microfilarial dynamics in the body, or a combi-
nation of these mechanisms. The observed stability of microscopy-diagnosed microfilarial
status (positive or negative) over significant time periods (in the order of years) in individuals
living in endemic areas could be consistent with any of these explanations but does at least
indicate that individuals maintain relatively stable (possibly very low) levels of infection (or remain
consistently uninfected) throughout their lifetime [64,83,84].
Patterns of Microfilarial Infection by Human Age and Sex
In contrast with diseases caused by soil-transmitted helminths and schistosomes, whose
worm burdens often peak in the young (excepting hookworm) [65], the age-specific patterns of
L. loa microfilariae infection typically involve prevalence increasing monotonically with age
[70,84,85] (Figure 4A). For schistosomiasis, the observation of a convex infection pattern is
thought to be due to the slow development of acquired immunity to reinfection [86]. Such a
peak is not observed for loiasis, suggesting that if there is a substantive role for protective
immunity in shaping individual responses to loiasis, it is likely to be either innate or rapidly
acquired, rather than gained gradually over many years of exposure to the parasite.(A) (B)Prevalence of infecon Intensity of infecon
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Figure 4. Patterns of Loa loa Infection by Human Host Age and Sex in the Administrative Division of Lekie in
Central Cameroon. Markers represent the prevalence of microfilariae (MF) in blood (A) and the arithmetic mean number
of microfilariae per ml of blood (B) in 10-year age groups plotted against the mean age within each group. Yellow markers
refer to women, green markers to men. For prevalence estimates, confidence intervals were calculated using the Clopper–
Pearson exact method [102]. For microfilarial infection intensity, the arithmetic means include both microfilariae-positive
and -negative individuals (i.e., 0 and positive counts), and error bars represent 95% credible intervals for the mean of a
zero-inflated negative binomial distribution fitted (using a Bayesian approach with uninformative/vague priors) to the
individual data for each age-category and sex [103]. Data are from [62].
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Outstanding Questions
What is the global burden of disease
due to morbidity and mortality associ-
ated with L. loa infection, and how
could we best quantify its disability
weights?
What will be the indirect impact of
interventions targeting onchocerciasis
and/or lymphatic filariasis on loiasis in
the regions of Central Africa receiving
regular preventive chemotherapy with
anthelmintics such as ivermectin? Will
such interventions be sufficient to elim-
inate loiasis in co [289_TD$DIFF]-endemic areas, or
will further loiasis-specific control mea-
sures be required?
In areas not co [289_TD$DIFF]-endemic with oncho-
cerciasis and/or lymphatic filariasis,
what interventions would be most
effective and cost-effective at inter-
rupting loiasis transmission and elimi-
nating the parasite, given its complex
and incompletely understood popula-
tion biology and epidemiology?
Are there any other density-dependent
processes operating within the para-
site’s life cycle and further regulating its
population abundance? If so, at what
stage are they acting, and to what
extent?
Is there a subset of the human popu-
lation who is genuinely amicrofilarae-
mic, or is this observation due to the
limited sensitivity of the currently avail-
able microscopy-based diagnostics?
Why is there such extreme variation in
the levels of microfilarial infection
among individuals? What are the rela-
tive roles of exposure, physiology, and
genetics underlying this observation?Like prevalence, mean intensity of microfilarial infection (averaging over both microfilaraemic
and amicrofilaraemic individuals) also increases with age (Figure 4B), although intriguingly, after
initial infection, an individual’s intensity of infection (microfilarial concentration in the blood, as
measured by microscopy) is relatively consistent over their lifetime. This has led researchers to
suggest that infections with L. loa are non [298_TD$DIFF]-cumulative [84], that is, observed increases in
average microfilarial infection intensity (across a community, including both microfilariae-posi-
tive and -negative individuals) primarily reflect an increase in the number of individuals infected,
rather than an increase in the parasite load of those already infected. This contrasts with many
other helminthiases where prevalence saturates with increasing average intensity of infection,
indicating that infection intensity is increasing in individuals already infected, but very few new
individuals are becoming infected.
L. loa infection also shows sex-specific patterns (Figure 4), with a number of studies demon-
strating that the prevalence of microfilarial infection is lower in females than in males across all
ages [70,87]. It has been suggested that these observations may be explained by either
occupationally mediated differences in exposure to infective tabanid vectors between men and
women, or by physiological differences between the sexes. One study has shown that
exposure is an important determinant of whether an individual is microfilaraemic or not [87],
providing support for differential exposure being a potentially important driver of epidemiologi-
cal patterns. However, these results contrast with those from an earlier study in which neither
exposure nor sex were significantly associated with microfilarial status [84].
Concluding Remarks and Future Perspectives
Recent work reporting excess human mortality associated with loiasis [7], and the large
numbers of people currently infected or at risk of infection [4] [299_TD$DIFF]suggest that the notion of
the disease as merely an impediment to the treatment of onchocerciasis and LF with ivermectin
underestimates the true magnitude of the problem. Loiasis should be recognised as an NTD of
significant public health importance worthy of attention and effort in its own right, and an
assessment of its global disease burden should be undertaken (see Outstanding Questions).
These initial steps would be vital to support optimal deployment of interventions to combat the
disease, and help the millions at risk of loiasis in Central Africa who have been largely ignored.
Designing and implementing interventions against loiasis will require further research in different
areas. These include better resolution of the spatial distribution of loiasis (particularly in
intermediate- and low-transmission areas), something that may be facilitated by the recently
developed antibody [300_TD$DIFF]-detecting lateral-flow assay [88], as well as investigation of interventions
other than ivermectin. Some work has already been carried out on this, including important
exploration of vector control options [10], as well as investigations into albendazole as a
treatment in instances where high blood microfilarial concentrations preclude treatment with
ivermectin [89], but more research is needed.
Perhaps one of the most pertinent and timely research avenues would be the development of
mathematical models of loiasis transmission and control. Given the often high levels of co [288_TD$DIFF]-
infection with onchocerciasis that exist in populations [79,90], the significant number of people
with onchocerciasis who have already received ivermectin, and the commitment to ensure
those still infected with O. volvulus receive the necessary treatment [91], it is likely that many
individuals currently infected with L. loa will receive, or have already received, ivermectin. More
recently, ‘test and not treat’ strategies have been proposed (and community trials imple-
mented) in which individuals with a high infection level (>20 000–30 000microfilariae perml) are
identified by rapid diagnostic tests (e.g., Cellscope Loa [92]) and not treated with ivermectin (the12 Trends in Parasitology, Month Year, Vol. xx, No. yy
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2%of the population) [92,93]. Without suitably constructedmathematical models, the impact of
these strategies on the transmission dynamics of loiasis will remain unclear and amenable only
to informal and less rigorous analysis. For example, it is known that community-directed
treatment with ivermectin can effect significant reductions in L. loa prevalence, both in humans
and in the Chrysops vectors [94,95]. But the impact of this intervention on loiasis transmission
among diverse transmission settings, and the prospects of elimination, remain unclear. Con-
struction of a mathematical model reflecting the epidemiological features of L. loa, both in the
vector and human host, would therefore assist in assessing the indirect impact of interventions
intended to control and eliminate onchocerciasis or LF and in evaluating the need for further
interventions specifically targeting loiasis.
It would also further help to explore and understand the complex epidemiology of the disease;
although loiasis shares similarities with other filarial infections, it is also marked by several
distinct features that must be specifically incorporated into mathematical models to accurately
reflect transmission dynamics, and in turn, whose incorporation will allow further exploration
and analysis of their key properties. These include the distinct ecology of the tabanid Chrysops
vectors (driven by an array of geographical and environmental factors [96,97] and with
consequences for the parasite’s transmission dynamics); the indicated role of individual-
and age-specific exposure to infection; the postulated presence of an amicrofilaraemic
subpopulation; the parasite’s lack of Wolbachia endosymbionts precluding the use of anti-
microbials as treatment (in contrast to onchocerciasis and LF against which they can be
employed) [98]; and the extremely high microfilarial loads that individuals can sustain and that
are associated with a risk of SAEs following treatment with microfilaricidal drugs. Indeed, in
individuals with high microfilaraemia there are no safe and effective treatment options (although
there are preliminary results suggesting that long courses of albendazole are safe and poten-
tially effective [99]), and research into new antifilarial treatments is urgently needed. These
features complicate the treatment and control of loiasis significantly, limiting the utility and safety
of formulating intervention strategies without recourse to rigorous mathematical models of
transmission dynamics. Construction of a mathematical model accurately reflecting the para-
site’s population biology and transmission dynamics will serve to increase our understanding of
this disease and facilitate the implementation of effective measures to control or eliminate
loiasis as a public health concern.
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